KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Receivables (2020 - 2025)

Oscar Health's Receivables history spans 6 years, with the latest figure at $442.6 million for Q4 2025.

  • For Q4 2025, Receivables rose 40.13% year-over-year to $442.6 million; the TTM value through Dec 2025 reached $442.6 million, up 40.13%, while the annual FY2025 figure was $442.6 million, 40.13% up from the prior year.
  • Receivables reached $442.6 million in Q4 2025 per OSCR's latest filing, down from $445.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $488.8 million in Q1 2025 to a low of $75.9 million in Q1 2021.
  • Average Receivables over 5 years is $258.4 million, with a median of $211.3 million recorded in 2022.
  • Peak YoY movement for Receivables: skyrocketed 111.89% in 2021, then dropped 7.02% in 2023.
  • A 5-year view of Receivables shows it stood at $138.4 million in 2021, then soared by 56.4% to $216.5 million in 2022, then decreased by 7.02% to $201.3 million in 2023, then surged by 56.95% to $315.9 million in 2024, then surged by 40.13% to $442.6 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Receivables are $442.6 million (Q4 2025), $445.5 million (Q3 2025), and $465.4 million (Q2 2025).